View Older Stories View More Recent Stories
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Bluevine Survey Shows 38% of SMBs Have Less Than a Month's Cash on Hand
-
Gold miners set for bumper profits after bullion's record rally
-
Mattel Inc. (MAT) PT Raised to $25 at Citi
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form 424B3 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Investa to Lead a New Era of Accessible Options Trading at The London Investor Show 2025
-
Citi Starts Newborn Town Inc (9911:HK) at Buy
-
Citi Upgrades HB Fuller (FUL) to Buy
-
Citi Upgrades BioAge Labs Inc (BIOA) to Buy
-
Citizens Reiterates Vertex (VRTX) at Market Outperform Rating; Management Sees Revenue Above Consensus
-
Citizens Reiterates Pegasystems (PEGA) at Market Outperform After Better-than-Expected Q3 Results
-
Citizens Reiterates Kaltura, Inc. (KLTR) at Market Outperform as Final Rating Ahead of CFO Departure
-
Citizens Reiterates Alphabet (GOOGL) at Market Outperform; Expects Strong 3Q25 Results
-
Citizens Reiterates Dynavax Technologies (DVAX) at Market Outperform Post Phase 1/2 Results
-
Citi Opens 90-Day Catalyst Watch on Atlassian Corporation (TEAM)
-
Citizens Reiterates DraftKings Inc. (DKNG) at Market Outperform; Expects Fairly Negative Quarter
-
OSB GROUP PLC - Transaction in Own Shares
-
Biomea Fusion to Participate in Citi's SMID Biotech C-Suite Fireside Chat Series
-
Biomea Fusion to Participate in Citi's SMID Biotech C-Suite Fireside Chat Series
-
Vale sees 2025 iron ore output at top range after strongest quarter since 2018
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Citius Pharmaceuticals closes $6 million direct offering

